Device
AKI alert
AKI alert is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
The Effect of Automated Electronic Alert for Acute Kidney Injury on the Outcomes of Hospitalized Patients
NCT03736304
completednot_applicable
Clinical Values of Automated Electronic Alert for Acute Kidney Injury
NCT02793167
completednot_applicable
Optimizing Electronic Alerts for Acute Kidney Injury
NCT02753751
Clinical Trials (3)
Showing 3 of 3 trials
NCT03736304Not Applicable
The Effect of Automated Electronic Alert for Acute Kidney Injury on the Outcomes of Hospitalized Patients
NCT02793167Not Applicable
Clinical Values of Automated Electronic Alert for Acute Kidney Injury
NCT02753751Not Applicable
Optimizing Electronic Alerts for Acute Kidney Injury
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3